Blockbuster weight loss drugs could slash the risk of developing memory-robbing dementia, a major study suggests. Researchers in Ireland analyzed clinical trials of nearly 165,000 taking drugs to lower their glucose (blood sugar) and treat diabetes. The team found most glucose-lowering treatments had no significant impact on dementia risk. However, people taking GLP-1 agonists like Ozempic and Wegovy were 45 …
Read More »Ozempic found to slash risk of disease affecting 6.7m Americans each year
